EsophaCap for the Detection of Early Esophageal Carcinoma
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Undergoing esophagogastroduodenoscopy at Johns Hopkins Hospital from 1/2016 to 12/2025
• Age greater than 18 years
• Patients must be able to swallow a capsule
Locations
United States
Maryland
Bayview Medical Center
RECRUITING
Baltimore
Johns Hopkins Hospital
RECRUITING
Baltimore
Contact Information
Primary
Stephen J Meltzer, M.D.
smeltzer@jhmi.edu
4105026071
Time Frame
Start Date: 2016-01-12
Estimated Completion Date: 2025-12-19
Participants
Target number of participants: 2500
Treatments
Control
Patients age 18 or greater who have undergone esophagogastroduodenoscopy and does not have a diagnosis of Barrett's esophagus or esophageal/gastric malignancy.
Barrett's esophagus
Patients age 18 or greater who have undergone esophagogastroduodenoscopy and diagnosed with Barrett's esophagus via pathology.
Esophageal carcinoma
Patients age 18 or greater who have diagnosis of primary esophageal carcinoma.
Gastric cancer
Patients age 18 or greater who have diagnosis of primary esophageal cancer.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: Johns Hopkins University